Trial Profile
Quetiapine and the dopaminergic epigenetic control - a pilot study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2020
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics; Pharmacogenomic
- 13 Jul 2008 Status changed from recruiting to completed.
- 23 Oct 2006 New trial record.